Cardiovascular Journal of Africa: Vol 28 No 3 (May/June 2017)

47 / 80

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 3, May/June 2017 AFRICA 181
31. Aziz AR, Wahid MF, Png W, Jesuvadian CV. Effects of Ramadan fast-
ing on 60 min of endurance running performance in moderately trained
men. Br J Sports Med 2010; 44(7): 516–521. PMID: 20519256.
32. Maughan RJ, Fallah J, Coyle EF. The effects of fasting on metabo-
lism and performance. Br J Sports Med 2010; 44(7): 490–494. PMID:
20484315.
33. Rivera-Brown AM, Frontera WR. Principles of exercise physiology:
responses to acute exercise and long-term adaptations to training. Phys
Med Rehab 2012; 4(11): 797–804. PMID: 23174541
34. Winnicki M, Phillips BG, Accurso V, van De Borne P, Shamsuzzaman
A, Patil K, et al. Independent association between plasma leptin levels
and heart rate in heart transplant recipients. Circulation 2001; 104(4):
384–386. PMID: 11468197.
35. Tritos NA, Kissinger KV, Manning WJ, Danias PG. Association
between ghrelin and cardiovascular indexes in healthy obese and lean
men. Clin Endocrinol (Oxf) 2004; 60(1): 60–66. PMID: 14678289.
36. Zoladz JA, Konturek SJ, Duda K, Majerczak J, Sliwowski Z, Grandys
M, et al. Effect of moderate incremental exercise, performed in fed
and fasted state on cardio-respiratory variables and leptin and ghrelin
concentrations in young healthy men. J Physiol Pharmacol 2005; 56(1):
63–85. PMID: 15795476.
37. Jenkins AB, Markovic TP, Fleury A, Campbell LV. Carbohydrate intake
and short-term regulation of leptin in humans. Diabetologia 1997; 40(3):
348–351. PMID: 9084976.
38. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima
M, et al. Upregulation of ghrelin expression in the stomach upon fast-
ing, insulin-induced hypoglycemia, and leptin administration. Biochem
Biophys Res Commun 2001; 281(5): 1220–1225. PMID: 11243865.
39. Schachinger H, Weinbacher M, Kiss A, Ritz R, Langewitz W.
Cardiovascular indices of peripheral and central sympathetic activation.
Psychosom Med 2001; 63(5): 788–796. PMID: 11573027.
40. Malpas SC. What sets the long-term level of sympathetic nerve activ-
ity: is there a role for arterial baroreceptors? Am J Physiol Regul Integr
Comp Physiol 2004; 286(1): R1–R12. PMID: 14660468.
41. Riggs TE, Shafer AW, Guenter CA. Acute changes in oxyhemoglobin
affinity. Effects on oxygen transport and utilization. J Clin Invest 1973;
52(10): 2660–2663. PMID: 4199605.
42. Dempsey JA, Rodriquez J, Shahidi NT, Reddan WG, MacDougall JD.
Muscular exercise, 2,3-DPG and oxy-hemoglobin affinity. Int Z Angew
Physiol 1971; 30(1): 34–39. PMID: 5136941.
43. Lettieri CJ, Nathan SD, Browning RF, Barnett SD, Ahmad S, Shorr AF.
The distance-saturation product predicts mortality in idiopathic pulmo-
nary fibrosis. Respir Med 2006; 100(10): 1734–1741. PMID: 16545950.
44. Bourbonnais JM, Malaisamy S, Dalal BD, Samarakoon PC, Parikh SR,
Samavati L. Distance saturation product predicts health-related quality
of life among sarcoidosis patients. Health Qual Life Outcomes 2012; 10:
67. PMID: 22694853.
Addendum
Time-Line and Next Steps
Proposal Submission by 1 June 2017
Decision notification by 15 June 2017
Implementation within 6 months (before end 2017)
Eligible recipients: individuals or organisations in members states in Africa
Selection Panel: PASCAR, WHF, and RHD Action
What is needed?
The rheumatic heart disease community in Africa is invited to propose an activity that will achieve at least one (and preferably more) of the following
objectives in their countries:
1. Promote policy on the AU Communiqué on National Programmes for the prevention and control of RHD with activities over 12 months (avoiding once
off activities) consistent with the objectives of the AU Communiqué Communique-2016.pdf)
2. Achieve implementation of a National Programme for prevention and control of RHD.
US $2,000 is available to fund the project or activity designed to achieve these objectives. Applications are invited from rheumatic heart disease champions
(organisations) based in Africa spelling out how this may be achieved in their country. PASCAR affiliated national societies will be at an advantage. The
proposal should address the following questions:
1. What is the track record of the applicant in rheumatic heart disease work?
2. What is the status of RHD prevention and control in your country?
3. What is the activity or event or strategy that will be used to achieve the stated objectives?
4. How will the funding be used to achieve the objectives (budget is required).
5. Who are the stakeholders that will be involved in the activity or events?
6. How will you involve the press in the activity or events?
The awards will be made to the five most deserving applicants based on the quality and credibility of the proposal with respect to answering the six questions
and likelihood of meeting the objectives outlined above within a period of 6 to 12 month from the award of the grant. Recipients of the grant will be expected
to provide a full report at the end of the project per template provided.
Applications should be submitted to Mr George Nel, PASCAR Executive Officer, before 1 June 2017.